|
Rossari Biotech Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2806.42 Cr.
|
P/BV
|
2.19
|
Book Value (Rs.)
|
231.78
|
|
52 Week High/Low (Rs.)
|
766/375
|
FV/ML
|
2/1
|
P/E(X)
|
18.81
|
|
Bookclosure
|
20/06/2025
|
EPS (Rs.)
|
26.94
|
Div Yield (%)
|
0.10
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2396.37 | 2071.46 | 1825.19 | 1651.32 | 1475.18 |
| Other Operating Revenues | 0.00 | 8.84 | 5.37 | 4.56 | 7.80 |
| Total Operating Revenues | 2396.37 | 2080.29 | 1830.56 | 1655.88 | 1482.97 |
| | | | | | |
| Other Income | 22.38 | 4.01 | 7.45 | 5.48 | 12.00 |
| Total Revenue | 2418.74 | 2084.30 | 1838.00 | 1661.37 | 1494.97 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1603.68 | 1299.64 | 1229.92 | 1079.11 | 970.12 |
| Purchase Of Stock-In Trade | 93.42 | 164.77 | 127.13 | 104.85 | 155.21 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -28.37 | -31.12 | -63.52 | -12.64 | -20.29 |
| Employee Benefit Expenses | 154.75 | 132.33 | 103.13 | 98.62 | 67.93 |
| Finance Costs | 28.54 | 17.81 | 19.37 | 22.32 | 12.66 |
| Depreciation And Amortisation Expenses | 79.12 | 67.07 | 60.39 | 62.93 | 48.06 |
| Other Expenses | 286.99 | 249.59 | 184.15 | 162.93 | 126.56 |
| Total Expenses | 2218.13 | 1900.10 | 1660.56 | 1518.10 | 1360.24 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 200.61 | 184.21 | 177.44 | 143.26 | 134.73 |
| | | | | | |
| Profit/Loss Before Tax | 200.61 | 184.21 | 177.44 | 143.26 | 134.73 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 53.30 | 59.07 | 55.79 | 49.13 | 47.01 |
| Deferred Tax | 0.00 | -10.26 | -8.86 | -12.17 | -8.43 |
| Total Tax Expenses | 53.30 | 48.81 | 46.93 | 36.96 | 38.58 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 147.31 | 135.40 | 130.51 | 106.30 | 96.15 |
| | | | | | |
| Profit/Loss From Continuing Operations | 147.31 | 135.40 | 130.51 | 106.30 | 96.15 |
| | | | | | |
| Profit/Loss For The Period | 147.31 | 135.40 | 130.51 | 106.30 | 96.15 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Share Of Profit/Loss Of Associates | 1.90 | 0.98 | 0.18 | 0.96 | 1.55 |
| Consolidated Profit/Loss After MI And Associates | 149.21 | 136.38 | 130.69 | 107.26 | 97.67 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 26.95 | 24.66 | 23.67 | 19.46 | 17.81 |
| Diluted EPS (Rs.) | 26.93 | 24.63 | 23.62 | 19.38 | 17.70 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 2.77 | 2.76 | 2.75 | 2.75 |
